» Articles » PMID: 17033267

Hyponatremia and Pituitary Adenoma: Think Twice About the Etiopathogenesis

Overview
Publisher Springer
Specialty Endocrinology
Date 2006 Oct 13
PMID 17033267
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Pituitary adenomas may be the cause of the syndrome of inappropriate secretion of antidiuretic hormone (SIADH), although few cases have so far been reported. We described a case of hypotonic hyponatremia in a 76-yr-old man with a pituitary macroadenoma. He had a recent history of two syncopal attacks which had occurred in the last two months. Baseline assessment demonstrated a sodium serum level of 114 mEq/l. Clinically, the patient appeared euvolemic. Thyroid and adrenal function testing did not show any abnormality. Plasma and urinary osmolality (238 and 186 mOsm/kg, respectively) were in agreement with the diagnosis of SIADH. Accordingly, 3% hypertonic saline solution was started, followed by water intake restriction when natremia reached 126 mEq/l. A computed tomography (CT) scan of the chest revealed the presence of a 2-cm lesion in the azygos-esophageal recess. Because the nature of the lesion appeared uncertain, antibiotic therapy was initiated. After one month, a new CT scan did not show any evidence of the mediastinic mass. Sodium serum level was within the normal range (141 mEq/l) and remained stable thereafter, without fluid restriction. This case very well demonstrates that, in the presence of hyponatremia due to SIADH, more frequently associated co-morbidities (ie mediastinic diseases) have to be searched, even in the presence of a possible, yet rare, cause of this syndrome (ie pituitary adenoma).

Citing Articles

Severe hyponatremia as an atypical manifestation of pituitary macroadenoma: a case report.

Yadav A, Kharel S, Shah B, Parajuli N Ann Med Surg (Lond). 2023; 85(5):2173-2176.

PMID: 37229053 PMC: 10205268. DOI: 10.1097/MS9.0000000000000676.


Hyponatremia and Oxidative Stress.

Fibbi B, Marroncini G, Anceschi C, Naldi L, Peri A Antioxidants (Basel). 2021; 10(11).

PMID: 34829639 PMC: 8614907. DOI: 10.3390/antiox10111768.


Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial.

Richmond P, Hatchuel L, Dong M, Ma B, Hu B, Smolenov I Lancet. 2021; 397(10275):682-694.

PMID: 33524311 PMC: 7906655. DOI: 10.1016/S0140-6736(21)00241-5.


Effects of low extracellular sodium on proliferation and invasive activity of cancer cells in vitro.

Marroncini G, Fibbi B, Errico A, Grappone C, Maggi M, Peri A Endocrine. 2019; 67(2):473-484.

PMID: 31784880 DOI: 10.1007/s12020-019-02135-0.


Tumor-related hyponatremia.

Onitilo A, Kio E, Doi S Clin Med Res. 2007; 5(4):228-37.

PMID: 18086907 PMC: 2275758. DOI: 10.3121/cmr.2007.762.

References
1.
Yatagai T, Kusaka I, Nakamura T, Nagasaka S, Honda K, Ishibashi S . Close association of severe hyponatremia with exaggerated release of arginine vasopressin in elderly subjects with secondary adrenal insufficiency. Eur J Endocrinol. 2003; 148(2):221-6. DOI: 10.1530/eje.0.1480221. View

2.
Morinaga K, Inoue Y, Ueda M, Matsumoto Y, Omiya N, Mikami J . [An interesting case of pituitary apoplexy showing abnormality in water-electrolyte before and after surgery]. No To Shinkei. 1990; 42(10):907-11. View

3.
Greiss K, Moses A, Krieger D . Pituitary adenoma associated with inappropriate antidiuretic hormone secretion. Acta Endocrinol (Copenh). 1974; 76(1):59-66. DOI: 10.1530/acta.0.0760059. View

4.
Minniti G, Esposito V, Piccirilli M, Fratticci A, Santoro A, Jaffrain-Rea M . Diagnosis and management of pituitary tumours in the elderly: a review based on personal experience and evidence of literature. Eur J Endocrinol. 2005; 153(6):723-35. DOI: 10.1530/eje.1.02030. View

5.
Kanda M, Omori Y, Shinoda S, Yamauchi T, Tamemoto H, Kawakami M . SIADH closely associated with non-functioning pituitary adenoma. Endocr J. 2004; 51(4):435-8. DOI: 10.1507/endocrj.51.435. View